TickerFactsScreenerDevelopers

Caribou Biosciences, Inc. (CRBU) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $41.07M2020: $15.95M2021: $240.42M2022: $58.34M2023: $51.16M2024: $16.29M2025: $12.36M$12.36M
2019Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$12.36M-24.1%
2024$16.29M-68.2%
2023$51.16M-12.3%
2022$58.34M-75.7%
2021$240.42M+1407.1%
2020$15.95M-61.2%
2019$41.07M—